SCHEMBL7973564

SCHEMBL7973564

CCOC(Cl)=C(C=O)c1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)ccc1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 2/20 0.33
CTDSP1 Q9GZU7 2/20 0.33
NSD2 O96028 1/20 0.33
PKM P14618 1/20 0.33
APEX1 P27695 1/20 0.33
CASP3 P42574 1/20 0.33
RECQL P46063 1/20 0.33
CASP6 P55212 1/20 0.33
CTSB P07858 1/20 0.33
NOTUM Q6P988 2/20 0.33
KMT2A Q03164 2/20 0.32
BAZ2B Q9UIF8 1/20 0.32
BAZ2A Q9UIF9 1/20 0.32
BRD9 Q9H8M2 1/20 0.31
MAPK1 P28482 2/20 0.30
MAPT P10636 2/20 0.30
LMNA P02545 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6699195 0.86 CYP4F2 (0.44) TDP1ALDH1A1PKMCTSBNOTUM
SCHEMBL9168174 0.81 TDP1 (0.40) TDP1L3MBTL1ALDH1A1POLBCTDSP1
SCHEMBL29576263 0.81 TDP1 (0.40) TDP1L3MBTL1ALDH1A1POLBCTDSP1
SCHEMBL7973578 0.80 BCAT1 (0.43) ALDH1A1MAPTHTT
SCHEMBL9423187 0.80 TDP1 (0.38) TDP1L3MBTL1ALDH1A1POLBCTDSP1
SCHEMBL9368363 0.80 CTSB (0.36) TDP1L3MBTL1CTSBNOTUMKMT2A
SCHEMBL6553785 0.80 CYP4F2 (0.34) TDP1CTSBNOTUMKMT2ABAZ2B
SCHEMBL6553650 0.80 CYP4F2 (0.34) TDP1L3MBTL1ALDH1A1PKMCTSB
SCHEMBL6908332 0.80 ALDH1A1 (0.39) TDP1ALDH1A1CTSBNOTUMKMT2A
SCHEMBL7921773 0.79 ALDH1A1 (0.34) L3MBTL1ALDH1A1NOTUMBAZ2BBAZ2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031865-A1 Substituted 3-phenyluracils KLINTZ RALF (DE) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031865-A1 Substituted 3-phenyluracils CCR1, CCR6, CCR3 TDP1 1685/4885L3MBTL1 69/4885ALDH1A1 1864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.